 |
| Global Respiratory Tract Infection Treatment Market Size |
Respiratory tract infections constitute a large majority of infectious diseases
across the world. Some common respiratory tract infections include influenza,
whooping cough, acute bronchitis, and pneumonia. Rising air pollution levels,
changing climate, and increased vulnerability of the aging population have
contributed significantly to the rising incidence of respiratory diseases
across the world. The treatment of respiratory tract infections involves the
use of antibiotics, antivirals, and other medications to eliminate the
infection-causing pathogens. In recent years, there has been a growing demand
for innovative drug formulations and combination therapies for enhanced treatment
of respiratory diseases.
The global Respiratory Tract Infection Treatment Market is estimated to be
valued at US$ 103.19 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period
2024 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The increasing prevalence of respiratory diseases has accelerated the demand
for advanced treatment options in the respiratory tract infection treatment
market. According to the World Health Organization, respiratory diseases
accounted for over 4 million deaths globally in 2019. Further, changing
demographics with a rising geriatric population base has significantly
contributed to the growing disease incidence. Elderly individuals are more
susceptible to respiratory infections due to decreased immune function. The
development of newer drug formulations targeted towards the aging population is
expected to remain a key trend in the market over the forecast period. In
addition, the launch of combination therapies that target multiple
infection-causing pathogens simultaneously is anticipated to boost market
revenues.
Segment Analysis
The global respiratory tract infection treatment market is dominated by the
anti-bacterial drugs segment, which accounted for around 33% market share in
2024. This is because bacterial respiratory tract infections are among the most
common respiratory diseases, with conditions such as pneumonia, bronchitis, and
sinusitis usually requiring treatment with anti-bacterial drugs such as amoxicillin.
The anti-viral drugs segment is expected to witness fastest growth during the
forecast period owing to the increasing incidence of viral respiratory tract
infections such as influenza.
Key Takeaways
Global
Respiratory Tract Infection Treatment Market Size
is expected to witness high growth over the forecast period from 2024 to
2031. Rapid growth can be attributed to factors such as the rising prevalence
of respiratory diseases, growing elderly population that is more susceptible to
these infections, and increasing availability of advanced treatment options.
The global Respiratory Tract Infection Treatment Market is estimated to be
valued at US$ 103.19 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period
2024 to 2031.
Regional analysis
Asia Pacific is expected to dominate the global respiratory tract infection
treatment market during the forecast period. This is due to the large
population base and high disease incidence in highly populated countries such
as India and China. North America is expected to witness the fastest growth due
to well-established healthcare infrastructure and growing adoption of novel
drug therapies in the region.
Key players
Key players operating in the respiratory tract infection treatment market are
Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH,
Cipla Pharmaceutical Company, GlaxoSmithKline plc, Pfizer Inc., Merck &
Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical
Industries Ltd. Abbott Laboratories and GlaxoSmithKline plc collectively
account for over 25% of the global market share owing to their wide product
portfolio and strong brand presence.
Get More Insights On This Topic: https://www.newswirestats.com/global-respiratory-tract-infections-treatment-market-size/
Explore More Article: https://captionssky.com/what-are-thermoplastic-elastomers/